TP53 deletion is the most frequent tumor suppressor gene mutated in human SCCs and this alteration is usually sufficient for transforming benign tumors into malignant CSCCs when another oncogene (RAS or CCND1) is also mutated, as it occurs in many other solid tumor malignancies. This evidence concerns the gene CCND1 and benign neoplasm.